In Vivo Molecular Imaging and Histological Analysis of Changes Induced by Electric Pulses Used for Plasmid DNA Electrotransfer to the Skin: A Study in a Dorsal Window Chamber in Mice

Electropermeabilization/electroporation (EP) is a physical method that by application of electric pulses to cells increases cell membrane permeability and enables the introduction of molecules into the cells. One of the uses of EP in vivo is plasmid DNA electrotransfer to the skin for DNA vaccination. EP of tissues induces reduction of blood flow and, in combination with plasmid DNA, induction of an immune response. One of the EP protocols for plasmid DNA electrotransfer to the skin is a combination of high-voltage (HV) and low-voltage (LV) pulses. However, the effects of this pulse combination on skin-vessel blood flow are not known. Therefore, using intravital microscopy in a dorsal window chamber in mice and fluorescently labeled dextrans, the effects of one HV and eight LV pulses on skin vasculature were investigated. In addition, a detailed histological analysis was performed. Image analysis of fluorescence intensity changes demonstrated that EP induces a transient constriction and increased permeability of blood vessels as well as a “vascular lock.” Histological analysis revealed rounding up of endothelial cells and stacking up of erythrocytes at 1 h after EP. In addition, extravasation of erythrocytes and leukocyte infiltration accompanied by edema were determined up to 24 h after EP. In conclusion, our results show that blood flow modifying effects of EP in skin contribute to the infiltration of immune cells in the exposed area. When combined with plasmid DNA for vaccination, this could enable the initial and prolonged contact of immune cells with encoded therapeutic proteins.

[1]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[2]  C. Ottensmeier,et al.  DNA vaccines: precision tools for activating effective immunity against cancer , 2008, Nature Reviews Cancer.

[3]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[4]  Peter Clarys,et al.  In vivo assessment of skin electroporation using square wave pulses. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Damijan Miklavcic,et al.  Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells , 2010, Radiology and oncology.

[6]  F. Yuan,et al.  Enhancement of Electric Field-Mediated Gene Delivery Through Pretreatment of Tumors With a Hyperosmotic Mannitol Solution , 2010, Cancer Gene Therapy.

[7]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[8]  D. Weiner,et al.  DNA vaccines for targeting bacterial infections , 2010, Expert review of vaccines.

[9]  J. Gehl,et al.  Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. , 1999, Biochemical and biophysical research communications.

[10]  J. Tomich,et al.  Electrolysis and thermolysis for permanent hair removal. , 1985, Journal of the American Academy of Dermatology.

[11]  J. Teissié,et al.  Spatial compartmentation and time resolution of photooxidation of a cell membrane probe in electropermeabilized Chinese hamster ovary cells. , 1995, European journal of biochemistry.

[12]  Siqing Shan,et al.  In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters , 2011, Nature Protocols.

[13]  D. Montefiori,et al.  DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge , 2009, Proceedings of the National Academy of Sciences.

[14]  R. Barr,et al.  Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery , 2002, Gene Therapy.

[15]  D Miklavcic,et al.  Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma , 2008, British Journal of Cancer.

[16]  M. Čemažar,et al.  MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo , 2010, Cancer Gene Therapy.

[17]  R. Schülke.  [Anatomy and physiology]. , 1968, Zahntechnik; Zeitschrift fur Theorie und Praxis der wissenschaftlichen Zahntechnik.

[18]  Damijan Miklavcic,et al.  Non invasive contact electrodes for in vivo localized cutaneous electropulsation and associated drug and nucleic acid delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Yunpeng Cao,et al.  Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation , 2012, Journal of the Neurological Sciences.

[20]  N. Sardesai,et al.  Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. , 2011, The Journal of infectious diseases.

[21]  M. Katze,et al.  Long-Term Programming of Antigen-Specific Immunity from Gene Expression Signatures in the PBMC of Rhesus Macaques Immunized with an SIV DNA Vaccine , 2011, PloS one.

[22]  Damijan Miklavčič,et al.  Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .

[23]  J. Timmons,et al.  Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment , 2009, PloS one.

[24]  S. El-Kamary,et al.  Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  S. van Drunen Littel-van den Hurk,et al.  Electroporation for DNA immunization: clinical application , 2010, Expert review of vaccines.

[26]  A. Bast,et al.  Review: Ischaemia-reperfusion injury in flap surgery. , 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[27]  Constantino Carlos Reyes-Aldasoro,et al.  Estimation of Apparent Tumor Vascular Permeability from Multiphoton Fluorescence Microscopic Images of P22 Rat Sarcomas In Vivo , 2008, Microcirculation.

[28]  N. Sardesai,et al.  Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. , 2011, Vaccine.

[29]  F. Yuan,et al.  Electric field-mediated transport of plasmid DNA in tumor interstitium in vivo. , 2007, Bioelectrochemistry.

[30]  L. Mir,et al.  Nucleic Acids Electrotransfer-Based Gene Therapy (Electrogenetherapy): Past, Current, and Future , 2009, Molecular biotechnology.

[31]  Dai Fukumura,et al.  Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.

[32]  J. Sin,et al.  Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control. , 2011, DNA and cell biology.

[33]  M. Čemažar,et al.  Controlled systemic release of interleukin‐12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas , 2009, The journal of gene medicine.

[34]  D Miklavcic,et al.  Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. , 2008, Human gene therapy.

[35]  D. Barouch,et al.  Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of Human Immunodeficiency Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation , 2008, Journal of Virology.

[36]  J. Teissié,et al.  Muscle gene electrotransfer is increased by the antioxidant tempol in mice , 2011, Gene Therapy.

[37]  A. Bråve,et al.  Plasmid DNA vaccination using skin electroporation promotes poly‐functional CD4 T‐cell responses , 2011, Immunology and cell biology.

[38]  A. Luxembourg,et al.  Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. , 2010, Vaccine.

[39]  T. Kurata,et al.  Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. , 2000, Vaccine.

[40]  N. Sardesai,et al.  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  Torben Skovsgaard,et al.  Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. , 2002, Biochimica et biophysica acta.

[42]  J. Ulmer,et al.  Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo , 2000, The Journal of Immunology.

[43]  Damijan Miklavcic,et al.  Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases , 2010, Expert review of anticancer therapy.

[44]  C. Kanthou,et al.  The endothelial cytoskeleton as a target of electroporation-based therapies , 2006, Molecular Cancer Therapeutics.

[45]  J. Gehl,et al.  Efficacy of transgene expression in porcine skin as a function of electrode choice. , 2011, Bioelectrochemistry.

[46]  M. Rols,et al.  Gene Transfer: How Can the Biological Barriers Be Overcome? , 2010, The Journal of Membrane Biology.

[47]  D Miklavcic,et al.  Electrochemotherapy in treatment of tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[48]  N. Sardesai,et al.  Electroporation delivery of DNA vaccines: prospects for success. , 2011, Current opinion in immunology.

[49]  D. Weiner,et al.  Clinical applications of DNA vaccines: current progress. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  Jill Gilmour,et al.  In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers , 2011, PloS one.

[51]  R. Malone,et al.  Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  T. Obata,et al.  Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging , 2009, Gene Therapy.

[53]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[54]  E. Sandström,et al.  Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation , 2010, Vaccine.

[55]  M Cemazar,et al.  Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? , 2006, Current pharmaceutical design.

[56]  Préat,et al.  In vivo efficacy and safety of skin electroporation. , 1999, Advanced drug delivery reviews.

[57]  M. Rols,et al.  Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells , 2011, Proceedings of the National Academy of Sciences.

[58]  N. Pavselj,et al.  DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[59]  D. Coppola,et al.  Evaluation of a Novel Non-Penetrating Electrode for Use in DNA Vaccination , 2011, PloS one.